Connie Stephens

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

Phase I Study of 506U78 Administered on a Consecutive 5-Day Schedule in Children and Adults With Refractory Hematologic Malignancies

Joanne Kurtzberg, T J Ernst, Michael J. Keating et al. · Journal of Clinical Oncology · 2005 · 174 citations · Full text

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 2023 · 165 citations

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss et al. · Annals of Oncology · 1998 · 76 citations

Malignant Disease, Medicine, Clinical Trials +8

Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer

Beth Overley-Adamson, Carol M. Artlett, Connie Stephens et al. · Cancer Biology & Therapy · 2014 · 31 citations · Full text

Immunology, Pathology, Er Stress +18